镜像疗法
康复理疗
≈ ¥20-50
(≈ $3-7)
大约15-30分钟
免责声明：本站为医疗服务机构，页面信息部分由AI协助制作。健康相关信息不构成医疗建议。如有任何疑问，请咨询医疗专业人士。详情见免责声明
项目介绍
镜像疗法在一般公立医院参考费用约¥15-40，三甲医院参考费用约¥20-50，常用于相关诊断评估与就医安排，费用随医院及地区有所差异。
主要用途
Mirror therapy is primarily used for: 1) Alleviating phantom limb pain in amputees; 2) Improving motor recovery and reducing hemiparesis after stroke; 3) Managing complex regional pain syndrome (CRPS) Type I; 4) Enhancing functional hand use and reducing learned non-use in neurological rehabilitation; 5) Supporting pain modulation and cortical reorganization in chronic musculoskeletal pain conditions (e.g., post-surgical shoulder pain, focal dystonia). It is delivered as part of multidisciplinary neurorehabilitation programs.
正常值范围
Mirror therapy is a non-invasive, behavioral rehabilitation intervention—not a laboratory or diagnostic test with numerical biomarkers—so it has no defined 'normal range' or quantitative reference values. Clinical effectiveness is assessed qualitatively and functionally (e.g., reduction in phantom limb pain intensity on a 0–10 visual analog scale, improvement in Fugl-Meyer Assessment scores, or time to complete motor tasks). No standardized numeric thresholds or physiological parameters are measured.
偏低可能原因
Ineffective mirror therapy outcomes ('low response') may result from: 1) Inadequate patient adherence or inconsistent home practice; 2) Severe sensory-motor deficits or cortical reorganization limiting neural plasticity; 3) Presence of complex regional pain syndrome (CRPS) or central sensitization unresponsive to visual feedback; 4) Incorrect mirror setup (e.g., misalignment, poor lighting, or occlusion of reflection); 5) Cognitive impairment or neglect syndromes impairing attention to the mirrored illusion.
偏高可能原因
Enhanced or 'high-response' outcomes in mirror therapy are not pathological but reflect optimal therapeutic engagement and neuroplastic potential; contributing factors include: 1) Early initiation post-injury/stroke (<3 months), leveraging heightened cortical plasticity; 2) High baseline motivation and intact visuospatial processing; 3) Concurrent use with other evidence-based interventions (e.g., graded motor imagery, occupational therapy); 4) Personalized protocol (e.g., tailored duration, frequency, task complexity); 5) Absence of comorbid conditions that impede sensorimotor integration (e.g., severe depression, untreated neuropathy, or cerebellar lesions).